Literature DB >> 10672033

Positive and negative elements modulate the promoter of the human liver-specific alpha2-HS-glycoprotein gene.

F Banine1, C Gangneux, L Mercier, A Le Cam, J P Salier.   

Abstract

The human alpha2-HS-glycoprotein (AHSG) and the 63-kDa rat phosphoprotein (pp63) are homologous plasma proteins that belong to the fetuin family. AHSG and pp63 are involved in important functions such as inhibition of insulin receptor tyrosine kinase activity, inhibition of protease activities, and regulation of calcium metabolism and osteogenesis. Studies of the AHSG proximal promoter performed in vitro in rat and human cells indicate that several NF-1 and C/EBP binding sites exert a positive effect on its transcriptional activity. However, until now, no distal elements have been examined in this gene, in either species. We report that the human AHSG gene promoter acts in a liver-specific manner and is further controlled by three distal, 5'-flanking elements. The negative elements III and I are, respectively, located 5' and 3' of the positive element II. All three elements require the natural context of the human AHSG gene to fully exert their negative or positive effect. Element I harbours a single binding site for NF-1. This nuclear factor thus appears to be able to up- or downregulate the AHSG gene depending on the site it binds to. Elements I, II and possibly III are absent in the rodent Ahsg gene encoding pp63.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10672033     DOI: 10.1046/j.1432-1327.2000.01119.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Fetuin-A, a hepatocyte-specific protein that binds Plasmodium berghei thrombospondin-related adhesive protein: a potential role in infectivity.

Authors:  Deepa Jethwaney; Timothy Lepore; Saria Hassan; Kerrianne Mello; Radha Rangarajan; Willi Jahnen-Dechent; Dyann Wirth; Ali A Sultan
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Association of alpha2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels.

Authors:  Motoki Osawa; Wei Tian; Hidekazu Horiuchi; Mika Kaneko; Kazuo Umetsu
Journal:  Hum Genet       Date:  2004-12-09       Impact factor: 4.132

3.  Estrogen increases the transcription of human α2-Heremans-Schmid-glycoprotein by an interplay of estrogen receptor α and activator protein-1.

Authors:  C Qiu; X Liu; J Wang; Y Zhao; Q Fu
Journal:  Osteoporos Int       Date:  2014-02-07       Impact factor: 4.507

4.  AHSG gene variant is associated with leanness among Swedish men.

Authors:  Catharina Lavebratt; Sofia Wahlqvist; Louise Nordfors; Johan Hoffstedt; Peter Arner
Journal:  Hum Genet       Date:  2005-04-02       Impact factor: 4.132

5.  The inflammation-induced down-regulation of plasma Fetuin-A (alpha2HS-Glycoprotein) in liver results from the loss of interaction between long C/EBP isoforms at two neighbouring binding sites.

Authors:  Christophe Gangneux; Maryvonne Daveau; Martine Hiron; Céline Derambure; John Papaconstantinou; Jean-Philippe Salier
Journal:  Nucleic Acids Res       Date:  2003-10-15       Impact factor: 16.971

6.  Detection of genetic loci associated with plasma fetuin-A: a meta-analysis of genome-wide association studies from the CHARGE Consortium.

Authors:  Majken K Jensen; Richard A Jensen; Kenneth J Mukamal; Xiuqing Guo; Jie Yao; Qi Sun; Marilyn Cornelis; Yongmei Liu; Ming-Huei Chen; Jorge R Kizer; Luc Djoussé; David S Siscovick; Bruce M Psaty; Joseph M Zmuda; Jerome I Rotter; Melissa Garcia; Tamara Harris; Ida Chen; Mark O Goodarzi; Michael A Nalls; Margaux Keller; Alice M Arnold; Anne B Newman; Ron C Hoogeveen; Kathryn M Rexrode; Eric B Rimm; Frank B Hu; Vasan S Ramachandran; Ronit Katz; James S Pankow; Joachim H Ix
Journal:  Hum Mol Genet       Date:  2017-06-01       Impact factor: 5.121

Review 7.  The structure, biosynthesis, and biological roles of fetuin-A: A review.

Authors:  Endeshaw Chekol Abebe; Zelalem Tilahun Muche; Awigchew Behaile T/Mariam; Teklie Mengie Ayele; Melaku Mekonnen Agidew; Muluken Teshome Azezew; Edgeit Abebe Zewde; Tadesse Asmamaw Dejenie; Misganaw Asmamaw Mengstie
Journal:  Front Cell Dev Biol       Date:  2022-07-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.